Answers are grounded in this paper and cite their sources.
THE difficulties in consistently prolonging survival after orthotopic liver transplantation have been documented by us1 and by Calne.2 In this report we describe a new trial of orthotopic liver transplantation in 14 patients who were scheduled to be treated with cyclosporin A and prednisone. Two patients died during the operation. Ten (83 per cent) of the 12 patients who survived surgery and received the drugs are living after eight to 14 1/2 months; another lived for a year, before dying of a recurrence of cholangiocarcinoma. Although longer follow-up periods and more case studies will be required to establish the safety. . .
No takes yet. Share an insight, caveat, or question.
Starzl et al. (1981) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: